iphone "bionic pancreas" device used in human trial to treat diabetes
Posted July 25, 2014 by lorrainegenscript
Performing fundamental diabetes research or developing diabetes peptide drugs? Try our custom peptide synthesis services.
Feature News
In a recent study, researchers developed and performed human trials using a "bionic pancreas" consisting of reservoirs for
glucagon and insulin, 2 pumps, and an iphone 4s. The iphone, (with associated app of course) functioned as a receiver, processor,
and transmitter of signals measuring blood sugar levels and calculating the amount of glucagon or insulin to be pumped to the
patient, every 5 minutes. What motivated the development of the device?
-- END ---
| Contact Email | [email protected] |
| Issued By | lorraine xu |
| Country | United States |
| Categories | Medical |
| Tags | genscript us ainc , peptide synthesis |
| Last Updated | July 25, 2014 |